Results 131 to 140 of about 79,111 (306)
Photodynamic therapy is an approved treatment for primary, superficial, and small nodular basal cell carcinomas with a thickness of < 2 mm located on low-risk sites.
Erik Mørk+9 more
doaj +1 more source
Photodynamic Therapy of Experimental 9L Gliosarcoma
Yasuhiro Okuda+2 more
openalex +2 more sources
Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice [PDF]
SL Gibson+5 more
openalex +1 more source
Abstract We reviewed the current status and perspectives on salvage esophagectomy for initially unresectable locally advanced esophageal squamous cell carcinoma (ESCC) in the era of minimally invasive surgery and immunotherapy. Although the standard treatment for these patients is definitive chemoradiotherapy (CRT), the complete response rate to CRT ...
Hiroshi Saeki+4 more
wiley +1 more source
TGIF1 overexpression promotes glioma progression and worsens patient prognosis
This study is the first to comprehensively analyze and reveal TGIF1, as a new oncogene, is closely related to the malignancy‐related phenotype of glioma, and that TGIF1 could be an independent risk factor for poor prognosis of glioma, which is expected to become a new target for individualized treatment of glioma patients.
Baoya Wang+5 more
wiley +1 more source
Photodynamic Therapy for Early Stage Lung Cancer [PDF]
Thomas J. Dougherty
openalex +1 more source
Fifteen new dinuclear arene‐ruthenium (II)‐BODIPY conjugates were synthesized. Despite a fluorescence quenching effect, these conjugates can be used as fluorescent tracers. Their antiparasitic activity but also their toxicity against healthy human foreskin fibroblasts (HFFs) was reduced compared to the parent ruthenium compounds.
Oksana Desiatkina+6 more
wiley +1 more source
PREOPERATIVE PHOTODYNAMIC THERAPY IN LUNG CANCER
Hiroshi Sakai+9 more
openalex +2 more sources
Experimental Studies of Laser Photodynamic Therapy (4)
Ikuo Nakazawa+3 more
openalex +2 more sources
To further promote immune activation in the tumor microenvironment, tumor‐selective nanomodulators called RPST@IMQ were proposed, aiming to comprehensively activate endogenous tumor immunity by inducing death of immunogenic cancer cells and remodeling the tumor microenvironment, which demonstrated a great potential for application.
Cheng Zhang+10 more
wiley +1 more source